This point is effectively made in a recently conducted large trial, which states that, our understanding of the mechanisms of cardiovascular protection with [the GLP-1 agonist] semaglutide remains speculativeclinical benefit is [thought to be] achieved through multiple interrelated pathways. Acknowledgement of this evidence gap prompted our lab, through use of a large animal model of CAD that replicates the features of disease as it occurs in humans, to investigate the cardiac consequences of semaglutide administration
Yes, temperature damage significantly reduces or eliminates the appetite-suppressing and metabolic effects of semaglutide by degrading the GLP-1 agonist activity
That range matters
The legal status of peptides varies by jurisdiction
One of those, described as "Ozempic breath," refers to "a fishy smell in burps or bad breath," Neha Lalani, MD, an endocrinologist based in Lakeway, Texas, told Healthline